Clinical Treatment Experience in Severe and Critical COVID-19
Research Article
[키워드] age
Anti-inflammatory therapy
anticoagulant therapy
anticoagulation
carried
clinical
Comorbidity
coronavirus disease
COVID-19
Critical
Critical case
critical cases
critical COVID-19 patient
cured
cytokine
D-dimer
death
Diagnosis
died
Diseases
evaluate
experience
Factor
hospital
Hospitalization
hypersensitive C-reactive protein
Immunosuppression
infected cases
Inflammatory indicators
LDH
lymphocyte
Mortality
mortality rate
Occurrence
Older age
outcome
Patient
reduce
Retrospective study
Severe patient
significantly lower
suggested
thrombosis
time
treat
treated
Treatment
treatment effects
Wuhan, China
[DOI] 10.1155/2021/9924542 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1155/2021/9924542 PMC 바로가기 [Article Type] Research Article